Press Release - Company Data

Cardiome Reports Second Quarter 2014 Financial Results
Posted 2014-08-11 00:12NAI Editing
today reported financial results for the second quarter and six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in U.S.

Cardiome Pharma Corp. Announces Voting Results
Posted 2014-06-17 00:01NAI Editing
today announced the results of voting at its 2014 Annual General and Special Meeting of Shareholders held on June 16, 2014.

Cardiome Pharma Corp. Announces Additional Director Nominee for 2014 AGM
Posted 2014-06-09 23:39NAI Editing
today announced that pursuant to the increase in size of the Board of Directors to six members, as disclosed in the 2014 information circular, an additional director nominee will be included at its 20

Cardiome Announces Commercialization Partnership For AGGRASTAT® In Select European Markets
Posted 2014-05-19 23:43NAI Editing
today announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize AGGRASTAT® (tirofiban HCl) in selected European markets.

Cardiome Announces Commercialization Agreement with UDG Healthcare plc for BRINAVESS™ in Ireland
Posted 2014-05-04 23:41NAI Editing
today announced that an affiliate of CardiomePharma Corp.

Cardiome Enters Agreement With Vianex S.A. To Commercialize BRINAVESS In Greece
Posted 2014-03-27 23:43NAI Editing
today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization a

Cardiome Reports Fourth Quarter and Full Year 2013 Financial Results
Posted 2014-03-26 23:36NAI Editing
today reported financial results for the fourth quarter and year ended December 31, 2013. Amounts, unless specified otherwise, are expressed in U.S.

Cardiome Enters Into an Agreement to Distribute BRINAVESS in Spain
Posted 2014-03-18 23:14NAI Editing
today announced that the company has entered into a distribution agreement with Logista Pharma S.A., headquartered in Madrid, Spain, to distribute BRINAVESS™ (vernakalant IV) within the Spanish market

Cardiome Closes C$30 Million Primary And Secondary Common Share Offering
Posted 2014-03-10 23:57NAI Editing
and CarCor Investment Holdings LLC ("CarCor"), the shareholder from which Cardiome purchased Correvio LLC, are pleased to announce the closing of their previously announced bought deal prospectus offe

Cardiome Announces C$30 Million Primary and Secondary Common Share Offering
Posted 2014-02-19 23:44NAI Editing
and CarCor Investment Holdings LLC ("CarCor"), the shareholder from which Cardiome purchased Correvio LLC, are pleased to announce that they have entered into an agreement with a group of underwriters